The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

MS Basile, E Cavalli, J McCubrey… - Drug discovery today, 2022‏ - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global
health. The disregulation of the phosphatidylinositol 3-kinase/protein kinase B/mammalian …

Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID

M Dhawan, AA Rabaan, S Alwarthan, M Alhajri… - Vaccines, 2023‏ - mdpi.com
The COVID-19 pandemic has caused havoc all around the world. The causative agent of
COVID-19 is the novel form of the coronavirus (CoV) named SARS-CoV-2, which results in …

Evaluation of off-label rapamycin use to promote healthspan in 333 adults

TL Kaeberlein, AS Green, G Haddad, J Hudson… - Geroscience, 2023‏ - Springer
Rapamycin (sirolimus) is an FDA-approved drug with immune-modulating and growth-
inhibitory properties. Preclinical studies have shown that rapamycin extends lifespan and …

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

MAY Al-Nesf, HB Abdesselem, I Bensmail… - Nature …, 2022‏ - nature.com
COVID-19 complications still present a huge burden on healthcare systems and warrant
predictive risk models to triage patients and inform early intervention. Here, we profile 893 …

[HTML][HTML] Cellular senescence in immunity against infections

V Marrella, A Facoetti, B Cassani - International Journal of Molecular …, 2022‏ - mdpi.com
Cellular senescence is characterized by irreversible cell cycle arrest in response to different
triggers and an inflammatory secretome. Although originally described in fibroblasts and cell …

Blocking TNF signaling may save lives in COVID-19 infection

V Ablamunits, C Lepsy - Molecular Biology Reports, 2022‏ - Springer
Global vaccination effort and better understanding of treatment strategies provided a ray of
hope for improvement in COVID-19 pandemic, however, in many countries, the disease …

The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection

Z Xu, X Jiang, X Dai, B Li - Frontiers in Immunology, 2022‏ - frontiersin.org
Coronavirus disease 2019 (COVID-19) has been raging all around the world since the
beginning of 2020, and leads to acute respiratory distress syndrome (ARDS) with strong …

Structural analysis of SARS-CoV-2 ORF8 protein: pathogenic and therapeutic implications

A Valcarcel, A Bensussen, ER Álvarez-Buylla… - Frontiers in …, 2021‏ - frontiersin.org
Current therapeutic strategies and vaccines against SARS-CoV-2 are mainly focused on the
Spike protein despite there are other viral proteins with important roles in COVID-19 …

Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2

G Shi, AI Chiramel, T Li, KK Lai, AD Kenney… - The Journal of Clinical …, 2022‏ - jci.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
immunocompromised individuals is associated with prolonged virus shedding and evolution …

Autophagy inducer rapamycin treatment reduces IFN-I–mediated Inflammation and improves anti–HIV-1 T cell response in vivo

W Mu, V Rezek, H Martin, MA Carrillo, S Tomer… - JCI …, 2022‏ - pmc.ncbi.nlm.nih.gov
A hallmark of HIV-1 infection is chronic inflammation, even in patients treated with
antiretroviral therapy (ART). Chronic inflammation drives HIV-1 pathogenesis, leading to …